Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 May-Jun;23(3):197-204.
doi: 10.1111/j.1521-0391.2014.12099.x.

Implementing substance abuse group therapy clinical trials in real-world settings: challenges and strategies for participant recruitment and therapist training in the Women's Recovery Group Study

Affiliations

Implementing substance abuse group therapy clinical trials in real-world settings: challenges and strategies for participant recruitment and therapist training in the Women's Recovery Group Study

Shelly F Greenfield et al. Am J Addict. 2014 May-Jun.

Abstract

Background and objectives: Open-enrollment group therapy research is challenged by the participant recruitment necessary to ensure continuous group enrollment. We present successful strategies to overcome the following barriers during the Women's Recovery Group (WRG) two-site clinical trial (N = 158): maintenance of sample size and balanced gender randomization during continuous enrollment, maintenance of group attendance, and training and retention of therapists over the 24-month continuous group enrollment.

Methods: To increase recruitment, we targeted referral sources yielding the highest enrollment conversion at each site. Group sessions were consistently held regardless of group size. Therapists were trained in two teams allowing for coverage and uninterrupted treatment over 24 months.

Results: At both sites recruitment and enrollment increased with each successive quarter. Sample size and end date targets were met without disruptions in treatment. Group therapists reported high satisfaction with their training and treatment experiences.

Discussion and conclusions: These strategies supported targeted enrollment and study duration, stability of open-enrollment group therapy frame, and therapist retention and satisfaction.

Scientific significance: Applying these strategies can aid in providing evidence-based group therapy in both clinical and research settings.

PubMed Disclaimer

Conflict of interest statement

Declaration of Interest:

The authors report no conflicts of interest. Dr. Bailey discloses that she is the recipient of grants from the National Institute on Drug Abuse, Alkermes, Inc. BioDelivery Sciences International, Inc. and Titan Pharmaceuticals, Inc. Dr. Bailey has also received travel funds from Titan Pharmaceuticals. The authors alone are responsible for the content and writing of this paper.

Figures

Figure 1
Figure 1
Referral Sources at McLean
Figure 2
Figure 2
Referral Sources at SSTAR
Figure 3
Figure 3
Number of Participants Enrolled by Quarter
Figure 4
Figure 4
Number of Participants in Group Sessions

References

    1. Wells KB. Treatment research at the crossroads: The scientific interface of clinical trials and effectiveness research. Am J Psychiatry. 1999;156(1):5–10. - PubMed
    1. Lamb S, Greenlick M, McCarty D, editors. Bridging the Gap Between Practice and Research: Forging Partnerships with Community-Based Drug and Alcohol Treatment. Washington, D.C: National Academy Press; 1998. - PubMed
    1. Weiss RD, Jaffee WB, de Menil VP, Cogley CB. Group therapy for substance use disorders: What do we know? Harv Rev Psychiatry. 2004;12(6):339–350. - PubMed
    1. Washton AM. Group therapy with outpatients. In: Lowinson JH, Ruiz P, Millman RB, Langrod JG, editors. Substance Abuse: A Comprehensive Textbook. 4. Lippincott Williams & Wilkins; 2005. pp. 671–679.
    1. Morgan-Lopez AA, Fals-Stewart W. Analytic complexities associated with group therapy in substance abuse treatment research: Problems, recommendations, and future directions. Experimental and Clinical Psychopharmacology. 2006;14(2):265–273. - PMC - PubMed

Publication types